CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in MDXG — Mimedx Group, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,781,376
-$666,325 QoQ
Shares Held
1,241,916
-10.0% QoQ
Ownership
0.852%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 226 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. MDXG ranks #141 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in MDXG
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,781,376 | 1,241,916 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,447,701 | 1,379,165 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,256,617 | 1,219,589 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,199,255 | 1,031,412 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,673,329 | 1,092,198 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $8,767,337 | 1,153,597 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $13,444,055 | 1,397,511 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $8,483,196 | 1,435,397 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $9,304,710 | 1,342,671 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,019,880 | 1,171,413 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,947,048 | 1,134,213 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $7,847,750 | 1,076,509 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $6,548,639 | 990,717 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,183,071 | 933,452 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,590,543 | 931,850 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,637,512 | 918,994 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,552,209 | 735,507 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,526,028 | 748,626 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,422,959 | 732,278 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,358,455 | 719,217 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $8,809,617 | 704,206 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,696,161 | 455,938 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,012,851 | 441,944 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||